Stroke is a major cause of mortality and morbidity around the world. Microembolic signals (MES), as the markers of unstable atherosclerotic plaque, can predict the occurrence and prognosis of ischemic stroke (IS). MES can also assess the efficacy of antithrombotic agents and predict the recurrence probability of IS. Unstable plaques are the main source of MES; thus, numerous biomarkers of atherosclerotic plaque instability are highly likely to predict the presence of MES. This study aims to review recent biomarker candidates for MES or microembolism. Current research indicates that the following are independent markers for positive MES: high level of serum soluble P-selectin, chemokine (C-X-C motif) ligand 16 (CXCL16) and fibrinogen, high neutrophil count, reduced ratio of CD4+CD25 regulatory T cells (Tregs) and the C allele of tumor necrosis factor receptor superfamily member 11B (TNFRSF11B) rs3102735. However, a more integrated profile of biomarkers for MES is needed to improve the stratification of patients with carotid stenosis and enhance the effectiveness of therapeutic interventions and prevention for IS.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.cca.2017.10.028 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Microembolic signal detection in acute ischemic stroke: Clinical relevance and impact on treatment individualization-A narrative review.
Eur J Neurol
January 2025
Second Department of Neurology, School of Medicine, "Attikon" University Hospital, National and Kapodistrian University of Athens, Athens, Greece.
Background: Microembolic signals (MES) can be detected using transcranial Doppler (TCD) ultrasound in several clinical scenarios, including acute ischemic stroke (AIS). This narrative review aims to provide insights into their role in AIS patient management and outcomes.
Methods: The present narrative review consolidates current observational and randomized evidence on the prevalence and clinical relevance of MES in different AIS subtypes and settings.
Incidence of Microembolic Signals on Transcranial Doppler among Patients with Symptomatic Carotid Near Occlusion.
Eur J Vasc Endovasc Surg
November 2024
Institution of Clinical Sciences, Department of Neurosciences, Umeå University, Umeå, Sweden; Institute of Neuroscience and Physiology, Department of Clinical Neuroscience, Sahlgrenska Academy, Gothenburg, Sweden; Wallenberg Centre of Molecular Medicine, Umeå University, Umeå, Sweden.
Article Synopsis
- The study investigates the causes of ischaemic stroke in patients with symptomatic carotid near occlusion, focusing on whether an embolic or haemodynamic mechanism is responsible.
- Researchers compared the occurrence of microembolic signals (MES) in patients with symptomatic near occlusion, symptomatic conventional ≥ 50% stenosis, and asymptomatic ≥ 50% stenosis to determine the differences.
- Findings revealed that MES incidence was significantly higher in symptomatic near occlusion patients compared to both symptomatic conventional stenosis and asymptomatic cases, suggesting a potential link to increased embolic activity.
The immunopathology of coronary microembolization and the underlying inflammopathophysiological mechanisms.
Allergol Immunopathol (Madr)
November 2024
Department of ICU, Wuhan Wuchang Hospital, Wuhan, China;
In coronary microembolization, inflammatory cell infiltration, patchy necrosis, and extensive intra-myocardial hemorrhage are dominant, which induce myocardial dysfunction with clinical symptoms of chronic ischemic cardiomyopathy. Microembolization can lead to obstruction of the coronary microvessels and result in the micro-infarction of the heart. The inflammation and elevated expression of the tumor necrosis factor in cardiomyocytes and the activation of extracellular ERK are involved in initiating the inflammatory response mechanism.
View Article and Find Full Text PDFBezafibrate mitigates cardiac injury against coronary microembolization by preventing activation of p38 MAPK/NF-κB signaling.
Aging (Albany NY)
October 2024
Department of Cardiology, Chongyi People’s Hospital, Ganzhou 341399, Jiangxi Province, China.
Article Synopsis
- The study looked at how a drug called Bezafibrate can help protect the heart from damage caused by coronary microembolization (CME), which is when small blood clots block tiny heart blood vessels.
- Researchers tested Bezafibrate on rats with heart damage and found that it improved heart function, reduced markers of injury, and lowered inflammation.
- Bezafibrate was also shown to prevent heart cell death and act through certain biological pathways, suggesting it could be a helpful treatment for heart problems related to CME.
Unusual Evidence of Fat Embolism in the Subclavian Vein Detected by High-Intensity Transient Signals.
Methodist Debakey Cardiovasc J
September 2024
Houston Methodist, Houston, Texas, US.
Fat emboli may occur in patients after traumatic fractures or orthopedic procedures; however, their clinical detection is a very rare finding. Here, we describe a 77-year-old female who was admitted to the emergency department with a fracture of the right humerus. We diagnosed fat embolism after an ultrasound of the right subclavian vein.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!